An editor has nominated this article for deletion. You are welcome to participate inthe deletion discussion, which will decidewhether to keep it. Feel free to improve the article, but do not remove this notice before the discussion is closed. For more information, see theguide to deletion. Find sources: "2023 Nobel Prize in Physiology or Medicine" – news ·newspapers ·books ·scholar ·JSTOR%5B%5BWikipedia%3AArticles+for+deletion%2F2023+Nobel+Prize+in+Physiology+or+Medicine%5D%5DAFD |
| Katalin Karikó andDrew Weissman | ||||
"for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19." | ||||
| Date | 2 October 2023 (2023-10-02) | |||
| Location | Stockholm | |||
| Country | Sweden | |||
| Presented by | Nobel Assembly at Karolinska Institutet | |||
| Reward | 11 millionSEK (2023)[1] | |||
| First award | 1901 | |||
| Website | 2023 Nobel Prize in Physiology or Medicine | |||
| ||||
The2023 Nobel Prize in Physiology or Medicine was awarded toKatalin Karikó (born 1955) andDrew Weissman (born 1959) "for their discoveries concerning nucleoside base modifications that enabled the development of effectivemRNA vaccines againstCOVID-19".[2][3]
Katalin Karikó was born on January 17, 1955, inSzolnok, Hungary.[4] From theUniversity of Szeged, she received aPh.D. in biochemistry in 1982.[5] From 2013 to 2022, she was associated with BioNTech RNA Pharmaceuticals, first as a vice president and promoted to senior vice president in 2019. This company, a division ofBioNTech, commercialized mRNA vaccines at a global scale.
Drew Weissman was born on September 7, 1959, inLexington, Massachusetts[6] and received aPh.D. in 1987 atBoston University.[7] He started studying RNA at theUniversity of Pennsylvania in 1997,[8] where he met Karikó.[9]
These are key publications by Karikó and Weissman related to the 2023 prize:[10]